The Parker Institute for Cancer Immunotherapy announced that Dr. Phil Greenberg, head of the Program in Immunology at the Hutch, has joined its team of more than 300 scientists from the academic, nonprofit, biotech and pharma sectors.
Study of three-step treatment approach reopens question of donor bone marrow transplant
Nov. 9, 2017
| by Susan Keown / Fred Hutch News Service
A new study offers a clue for solving a long-standing controversy in multiple myeloma: namely, whether a bone marrow transplant from a donor could be beneficial for patients with this disease and, if so, for which patients.